Integrating amyloid PET imaging data and anatomical imaging data into the current tau PET-based framework would contribute to building a comprehensive imaging-level understanding of the heterogeneity in AD (Jack Jr et al., 2016, 2018). The gene discussed is MAPT; the disease is Alzheimer disease.